Skip to main content
Clinical Trials/ISRCTN34153772
ISRCTN34153772
Completed
未知

A randomised controlled trial of topical intranasal tranexamic acid versus placebo to reduce the need for nasal packing in patients presenting to the Emergency Department with spontaneous epistaxis

Royal Devon and Exeter NHS Foundation Trust0 sites496 target enrollmentJune 1, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Royal Devon and Exeter NHS Foundation Trust
Enrollment
496
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30772866 protocol 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33612282/ (added 06/07/2021)

Registry
who.int
Start Date
June 1, 2017
End Date
June 30, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Royal Devon and Exeter NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 or over, any gender
  • 2\. Presenting to the ED with spontaneous, atraumatic epistaxis, unresolved with simple first aid and standard initial therapy

Exclusion Criteria

  • 1\. Clinical evidence of shock, as determined by the treating clinician, or requirement for resuscitation (including but not limited to systolic BP\< 90 mmHg).
  • 2\. Known allergy to TXA
  • 3\. Lacking capacity
  • 4\. Unwilling to give consent
  • 5\. No telephone or unwilling to be contacted by telephone
  • 6\. Known paranasal, nasopharyngeal or nasal cavity malignancy
  • 7\. Pregnancy
  • 8\. Sent to ED for specialist ENT treatment
  • 9\. Already undergone pre\-hospital nasal packing
  • 10\. Prior participation in the study (i.e. received allocated treatment)

Outcomes

Primary Outcomes

Not specified

Similar Trials